Welcome to the Journal of Taibah University Medical Sciences, a distinguished open-access publication dedicated to advancing knowledge in the field of medicine. Since its inception in 2006, and published by ELSEVIER, this journal has become a vital resource for researchers and healthcare professionals alike, reflecting a steadfast commitment to disseminating innovative research and high-quality medical studies. With an impressive impact factor and a Scopus ranking placing it in the top 25% of general medicine journals, this publication occupies a notable position in the academic landscape. The journal covers a wide array of topics within the medical sciences, from clinical research to public health initiatives. As a Q3 category journal in the 2023 rankings, it continues to attract submissions that contribute meaningfully to the diverse and evolving field of medicine, supporting an open-access model that ensures widespread accessibility to its invaluable content. Explore the Journal of Taibah University Medical Sciences to stay abreast of the latest scientific advancements and engage with fellow scholars across the globe.

Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.

The Electronic Journal of General Medicine is a distinguished open-access publication dedicated to advancing the field of general medicine through the dissemination of high-quality research and innovative practices. Published by MODESTUM LTD in the United Kingdom, this journal has been a pivotal platform for medical professionals and researchers since 2018, with an impressive Scopus ranking of #145 out of 636 in the Medicine category, placing it in the 77th percentile. It holds a Q3 quartile ranking in the 2023 medicine (miscellaneous) category, underscoring its relevance and contribution to the academic community. The journal focuses on a wide range of topics within general medicine, inviting original research articles, reviews, and case studies that address contemporary medical challenges. By providing a straightforward publication avenue, the Electronic Journal of General Medicine fosters knowledge exchange and stimulates scholarly dialogue, making it an essential resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments in the field.

Mayo Clinic Proceedings is a premier peer-reviewed medical journal published by Elsevier Science Inc, dedicated to advancing clinical practice through high-quality research, reviews, and case reports since its inception in 1945. With an impressive impact factor and recognized as a Q1 journal in the Medicine (miscellaneous) category, it ranks as #21 out of 636 in the realm of General Medicine, placing it in the top 96th percentile among its peers. The journal serves as a vital resource for healthcare professionals, researchers, and students by promoting evidence-based medicine that addresses contemporary challenges in clinical practice. Although it does not currently offer open access options, its rigorous publication standards ensure that its findings are credible and relevant, making it an essential platform for disseminating significant medical advancements. With a commitment to progress in healthcare, the Mayo Clinic Proceedings continues to shape the future of medicine for audiences across the globe.

WIENER MEDIZINISCHE WOCHENSCHRIFT, published by SPRINGER WIEN, stands as a pivotal journal in the field of general medicine, with a significant history dating back to its inception in 1946. With its ISSN 0043-5341 and E-ISSN 1563-258X, this journal seeks to bridge the gap between research and clinical practice, offering a platform for the dissemination of vital medical knowledge and innovations. While currently placed in the Q3 quartile of the medicine category and ranking #210 out of 636 in Scopus, it boasts a 67th percentile ranking, underscoring its impact and relevance among practitioners and researchers alike. Although not an open-access journal, its accessibility through institutional subscriptions ensures that a wide audience can engage with its comprehensive articles that cover myriad topics in medicine. As the field continuously evolves, WIENER MEDIZINISCHE WOCHENSCHRIFT is committed to advancing medical understanding and fostering discussions that resonate within Austria and beyond, making it an essential resource for healthcare professionals, academia, and students seeking to stay abreast of current medical advancements.

HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.

JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION (JPMA), published by the Pakistan Medical Association, serves as a vital platform for the dissemination of peer-reviewed research in the field of general medicine. Established in 1966, this journal has grown to cater to a diverse audience of healthcare professionals, researchers, and students, delivering crucial insights into the evolving landscape of medical science in Pakistan and beyond. With an ISSN of 0030-9982, JPMA aims to bridge knowledge gaps by publishing high-quality original articles, reviews, and case studies, fostering academic excellence and enhancing clinical practice. While the journal currently holds a Q4 category in Medicine (miscellaneous), it ranks #331 out of 636 in the Scopus database, placing it within the 48th percentile among its peers. The journal's critical role in shaping medical discourse ensures it remains an essential resource for advancing healthcare standards and improving patient outcomes.

ANNALS ACADEMY OF MEDICINE SINGAPORE is a reputable journal dedicated to the field of medicine, published by the Academy of Medicine, Singapore. With an E-ISSN of 2972-4066, this journal has been an influential platform since its inception in 1973, aiming to disseminate high-quality research and clinical findings pertinent to both local and international audiences. Currently ranked in the Q3 quartile in Medicine (miscellaneous), it holds a commendable 83rd percentile in Scopus rankings, indicating its significant academic contribution within the competitive landscape of medical literature. Although the journal operates on a traditional subscription-based model, it continues to provide access to critical insights that serve not only researchers but also healthcare professionals and students engaged in the ever-evolving medical sector. As it approaches its comprehensive publication mark in 2024, ANNALS will continue to focus on enhancing global healthcare discourse, making it an invaluable resource for those committed to advancing medical knowledge and practice.

CLINICAL DRUG INVESTIGATION is a prestigious journal dedicated to the fields of Medicine and Pharmacology, published by ADIS INT LTD in the United Kingdom. With an ISSN of 1173-2563 and an E-ISSN of 1179-1918, this journal has been a crucial contributor to the scientific community since its inception in 1995. Recognized for its significant impact, it holds a commendable Q2 ranking in both the Medicine (miscellaneous) and Pharmacology (medical) categories, placing it firmly in the 70th percentile within its field. Researchers, professionals, and students alike benefit from its commitment to publishing innovative studies and comprehensive reviews that advance understanding and application of clinical drugs. Although it does not currently offer open access options, its rigorous peer-review process ensures the integrity and quality of published articles. The journal's scope encompasses a wide range of topics related to drug investigation, making it an essential resource for anyone involved in medical research and pharmacological practice.

ADVANCES IN THERAPY is a prestigious peer-reviewed journal published by SPRINGER, specializing in the diverse fields of medicine and pharmacology. Established in 1984, this influential journal has become an essential resource for researchers and professionals, boasting a commendable impact factor and categorically ranking within the Q1 quartile in both Medicine (Miscellaneous) and Medical Pharmacology as of 2023. With an impressive Scopus ranking at #52 out of 272 in the realm of medical pharmacology, it places itself in the top 81st percentile, underscoring its importance in advancing therapeutic knowledge and practices. Although the journal is not open access, it provides invaluable insights and the latest research findings in therapies that significantly impact patient care, making it a vital reference for clinicians, academicians, and students alike.